Indeed, cytosine deaminase activity was generally higher in extracts from mutant p53 lines than in lysates from cells with WT p53 (Figure 5A and Supplementary Figure S6A), consistent with the elevated A3B expression levels in breast cancer cells with mutant p53. Here, APOBEC3B is linked to breast carcinoma.